Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-07-18
2006-07-18
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
Reexamination Certificate
active
07078437
ABSTRACT:
The invention contemplates drugs useful for maintenance or promotion at sites of regenerating nerves and for prevention or treatment of pathological conditions caused by denaturation or cell damage in the nervous system. Thus, the invention provides an apolipoprotein D degradation inhibitor containing lauric acid or oleic acid as an active ingredient.
REFERENCES:
patent: 3395236 (1968-07-01), White
patent: 4178376 (1979-12-01), Higuchi et al.
patent: 4983396 (1991-01-01), Bodor et al.
patent: 5034414 (1991-07-01), Wakabayashi et al.
patent: 5284657 (1994-02-01), Lu et al.
patent: 5393551 (1995-02-01), Arcadipane
patent: 5658957 (1997-08-01), Martin
patent: 2003/0024011 (2003-01-01), Dehesh et al.
patent: 2005/0196443 (2005-09-01), Weinbach et al.
H. Kido, et al., “Inhibition of Chymase Activity by Long Chain Fatty Acids1”, Archives of Biochemistry and Biophysics, vol. 230, No. 2, May 1, 1984, pp. 610-614.
C. Zeng, et al., “A human axillary odorant is carried by apolipoprotein D”, Proc. Natl. Acad. Sci. USA, vol. 98, Jun. 1996, pp. 6626-6630.
E. A. Thomas, et al., “Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: Implications for the pathophysiology of psychiatric disorders”, Proc. Natl. Acad. Sci. USA, vol. 98, No. 7, Mar. 27, 2001, pp. 4066-4071.
E. Rassart, et al., “Apolipoprotein D”, Biochimica et Biophysics Acta, vol. 1482, 2000, pp. 185-198.
Akiba Shun-ichi
Ara Katsutoshi
Kusuoku Hiroshi
Nishizawa Yoshinori
Henley III Raymond J.
Kao Corporation
LandOfFree
Apolipoprotein D degradation inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apolipoprotein D degradation inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apolipoprotein D degradation inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3567613